Barr Joins Challenge To Zyprexa Patent
Three years after Barr Laboratories Inc. successfully challenged the patent on Eli Lilly's blockbuster antidepressant Prozac, the company has set its sights on the patent for Lilly's new top-selling drug, the...To view the full article, register now.
Already a subscriber? Click here to view full article